GCM
NVO

Gallacher Capital Management’s Novo Nordisk NVO Stock Holding History

Gallacher Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$549K Buy
11,461
+2,361
+26% +$101K 0.31% 95
2026
Q1 		$334K Buy
9,100
+130
+1% +$6.16K 0.13% 210
2025
Q4 		$456K Sell
8,970
-3,852
-30% -$197K 0.18% 165
2025
Q3 		$711K Buy
12,822
+6,270
+96% +$367K 0.28% 91
2025
Q2 		$452K Buy
6,552
+144
+2% +$9.79K 0.21% 140
2025
Q1 		$445K Buy
6,408
+699
+12% +$57.7K 0.22% 133
2024
Q4 		$491K Buy
5,709
+57
+1% +$6.16K 0.24% 96
2024
Q3 		$673K Buy
5,652
+182
+3% +$24.3K 0.31% 58
2024
Q2 		$781K Sell
5,470
-413
-7% -$54.7K 0.41% 46
2024
Q1 		$755K Sell
5,883
-191
-3% -$22.7K 0.38% 43
2023
Q4 		$628K Sell
6,074
-242
-4% -$23.9K 0.35% 41
2023
Q3 		$574K Buy
6,316
+24
+0.4% +$2.11K 0.36% 47
2023
Q2 		$509K Buy
6,292
+258
+4% +$21.1K 0.29% 77
2023
Q1 		$480K Sell
6,034
-570
-9% -$40.4K 0.29% 79
2022
Q4 		$447K Buy
+6,604
New +$387K 0.27% 80

Other funds holding NVO

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Gallacher Capital Management's NVO Position: Q2 2026 in Review

Gallacher Capital Management increased its Novo Nordisk (NVO) stake by 26% in Q2 2026, buying an estimated $101K and bringing the position to 11,461 shares worth $549K. The position accounts for 0.31% of the portfolio, ranked #95.

Gallacher Capital Management first reported a position in NVO in Q4 2022 and has held it in 15 quarters since. The position peaked at $781K in Q2 2024. 310 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Gallacher Capital Management held 11,461 shares of Novo Nordisk worth $549K as of Q2 2026.
  • Gallacher Capital Management bought 2,361 Novo Nordisk shares in Q2 2026, an estimated $101K.
  • Novo Nordisk made up 0.31% of Gallacher Capital Management's portfolio in Q2 2026, its #95 holding.
  • Gallacher Capital Management first reported a position in Novo Nordisk in Q4 2022 and has held it in 15 quarters since.
  • Gallacher Capital Management's Novo Nordisk position peaked at $781K in Q2 2024.
  • 310 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.